Clinical Features of Endocrine Disorders with Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer

Immune checkpoint inhibitors(ICIs)could cause immune-related adverse events(irAEs), of which endocrine disorders are relatively common. Symptoms include fatigue, anorexia, and shock, making diagnosis and treatment difficult. This study aimed to analyze the characteristics of patients with non-small...

Full description

Bibliographic Details

Published in:	Gan to kagaku ryoho Vol. 50; no. 2; p. 177
Main Authors:	Takagi, Hironori, Muto, Satoshi, Fukuhara, Mitsuro, Inomata, Sho, Watanabe, Masayuki, Ozaki, Yuki, Okabe, Naoyuki, Matsumura, Yuki, Shio, Yutaka, Saito, Haruka, Ohe, Keitaro, Iyoda, Tomokazu, Shimabukuro, Michio, Kuroda, Junko, Suzuki, Hiroyuki
Format:	Journal Article
Language:	Japanese
Published:	Japan 01-02-2023
Subjects:	Carcinoma, Non-Small-Cell Lung - drug therapy Endocrine System Diseases Female Humans Immune Checkpoint Inhibitors - therapeutic use Lung Neoplasms - drug therapy Male Neoplasm Recurrence, Local - drug therapy Retrospective Studies
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!